A detailed history of Napatree Capital LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Napatree Capital LLC holds 5,249 shares of GILD stock, worth $485,899. This represents 0.31% of its overall portfolio holdings.

Number of Shares
5,249
Previous 5,797 9.45%
Holding current value
$485,899
Previous $398 Million 10.65%
% of portfolio
0.31%
Previous 0.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$66.59 - $83.99 $36,491 - $46,026
-548 Reduced 9.45%
5,249 $440 Million
Q2 2024

Aug 13, 2024

SELL
$63.15 - $72.88 $183,577 - $211,862
-2,907 Reduced 33.4%
5,797 $398 Million
Q1 2024

May 13, 2024

BUY
$71.58 - $87.29 $8,446 - $10,300
118 Added 1.37%
8,704 $568 Million
Q4 2023

Mar 26, 2024

BUY
$73.27 - $83.09 $629,096 - $713,410
8,586 New
8,586 $696 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Napatree Capital LLC Portfolio

Follow Napatree Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Napatree Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Napatree Capital LLC with notifications on news.